CORBUS PHARMACEUTICALS HOLDINGS INC. - COMMON STO

Corbus Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides a Corporate Update

06 أغسطس 2024 08:00:00 بحسب Nasdaq GlobeNewswire

NetDania - New 12 months High: CORBUS PHARMACEUTICALS HOLDINGS INC. - COMMON STO

31 يوليو 2024 10:44:31 بحسب NetDania Notify

Corbus Pharmaceuticals to Participate in Upcoming Investor Conferences in August

30 يوليو 2024 08:50:40 بحسب Nasdaq GlobeNewswire

NetDania - New 12 months High: CORBUS PHARMACEUTICALS HOLDINGS INC. - COMMON STO

16 يوليو 2024 09:55:39 بحسب NetDania Notify

NetDania - New 12 months High: CORBUS PHARMACEUTICALS HOLDINGS INC. - COMMON STO

15 يوليو 2024 10:01:36 بحسب NetDania Notify

NetDania - New 12 months High: CORBUS PHARMACEUTICALS HOLDINGS INC. - COMMON STO

12 يوليو 2024 10:50:10 بحسب NetDania Notify

NetDania - New 12 months High: CORBUS PHARMACEUTICALS HOLDINGS INC. - COMMON STO

12 يونيو 2024 09:45:05 بحسب NetDania Notify

NetDania - New 12 months High: CORBUS PHARMACEUTICALS HOLDINGS INC. - COMMON STO

11 يونيو 2024 16:10:04 بحسب NetDania Notify

NetDania - New 12 months High: CORBUS PHARMACEUTICALS HOLDINGS INC. - COMMON STO

03 يونيو 2024 10:16:45 بحسب NetDania Notify

SYS6002 (CRB-701) A Next-Generation Nectin-4 Targeting Antibody Drug Conjugate Continues to Demonstrate Encouraging Safety and Efficacy Observed in Patients with Nectin-4 Positive Tumors in a Clinical Update Presented at ASCO 2024

01 يونيو 2024 10:00:00 بحسب Nasdaq GlobeNewswire

Corbus Pharmaceuticals to Present at the 45th Annual Goldman Sachs Global Healthcare Conference

30 مايو 2024 08:00:00 بحسب Nasdaq GlobeNewswire

Updated Phase 1 Clinical Data for SYS-6002 (CRB-701) to be presented at 2024 ASCO Annual Meeting

23 مايو 2024 17:05:26 بحسب Nasdaq GlobeNewswire

NetDania - New 12 months High: CORBUS PHARMACEUTICALS HOLDINGS INC. - COMMON STO

21 مايو 2024 10:10:19 بحسب NetDania Notify

Corbus Pharmaceuticals to Participate in the 2024 RBC Capital Markets Global Healthcare Conference

09 مايو 2024 08:00:00 بحسب Nasdaq GlobeNewswire

Corbus Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Update

07 مايو 2024 08:00:01 بحسب Nasdaq GlobeNewswire

Corbus Pharmaceuticals to Participate in the BTIG Obesity Health Forum

01 مايو 2024 08:00:01 بحسب Nasdaq GlobeNewswire

Corbus Pharmaceuticals Announces Abstract Accepted for Presentation at 2024 ASCO Annual Meeting

24 أبريل 2024 16:05:00 بحسب Nasdaq GlobeNewswire

Corbus Announces Dosing of First Patient in U.S. Phase 1 Clinical Trial of Its Next Generation Nectin-4 Targeting ADC

02 أبريل 2024 08:01:11 بحسب Nasdaq GlobeNewswire

NetDania - New 12 months High: CORBUS PHARMACEUTICALS HOLDINGS INC. - COMMON STO

13 مارس 2024 09:45:14 بحسب NetDania Notify

Corbus Pharmaceuticals Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Corporate Update

12 مارس 2024 08:00:00 بحسب Nasdaq GlobeNewswire